ArticleMaterials (Basel, Switzerland)2025
Effect of Al on the Oxidation Behavior of TiCrZrNbTa High-Entropy Coatings on Zr Alloy.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study investigates the role of Al alloying in tailoring the oxidation resistance of AlTiCrZrNbTa refractory high-entropy alloy (RHEA) coatings on Zry-4 substrates under high-temperature steam environments. Coatings with varying Al contents (0-25 at.%) were deposited via magnetron sputtering and subjected to oxidation tests at 1000-1100 °C. The results demonstrate that Al content critically governs oxidation kinetics and coating integrity. The optimal performance was achieved at 10 at.% Al, above which a dense, continuous composite oxide layer (Al
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.